Efficacy and Safety of Pentoxifylline for Venous Leg Ulcers: An Updated Meta-Analysis

The venous leg ulcers are debilitating, painful, and often unresponsive to advanced dressing treatments, so drugs used locally and systematically are essential adjuvant therapy-pentoxifylline (PTX) whose anti-inflammatory effects may offer a promising avenue to treat venous leg ulcers. However, the current results are controversial. To further evaluate the efficacy and safety of PTX, we performed an updated meta-analysis of randomized placebo-controlled trials of PTX in the treatment of venous leg ulcers. We systematically searched multiple electronic databases PubMed, Web of Science, Embase, the Cochrane Library, the Cochrane Central Register of Controlled Trials, China Science and Technology Journal Database, WanFang Data, China National Knowledge Infrastructure, and the Chinese Biomedical Literature Database to identify eligible studies. Randomized clinical trials of pentoxifylline versus placebo treatment in patients with venous leg ulcers were considered for inclusion. The primary outcomes included ulcer healing rate and the incidence of adverse events after treatment. The secondary outcomes were the ulcer significant improvement (the ulcer size shrank by more than 60% after treatment) rate, mean duration of complete wound healing and changes in mean ulcer size. A meta-analysis and qualitative analysis were conducted to estimate endpoints. A total of 13 randomized clinical trials, including 921 individuals, were finally included. Compared with placebo, pentoxifylline significantly improved the ulcer healing rate (RR = 1.59, 95%CI 1.22 to 2.07, P < .001) and significant improvement rate (RR = 2.36, 95%CI 1.31 to 4.24, P = .004) while increased the incidence of gastrointestinal disturbances (RR = 2.29, 95%CI 1.04 to 5.03, P = .04) at the same time. Moreover, pentoxifylline also shortened mean duration of complete wound healing (P = .007) and shrank ulcer size (P = .02). Currently available evidence suggests that pentoxifylline could help venous leg ulcers heal more quickly and effectively. However, the evidence is insufficient to prove the results due to moderate-certainty evidence. Large-scale, well-designed randomized clinical trials are warranted.

[1]  B. Lin,et al.  Evaluation of static ulcer on lower extremities using wireless wearable near-infrared spectroscopy device: Effect of deep venous thrombosis on TRiggered Angiography Non-Contrast-Enhanced sequence magnetic resonance imaging , 2020, Phlebology.

[2]  L. Djouhri,et al.  A possible role for inducible arginase isoform (AI) in the pathogenesis of chronic venous leg ulcer , 2020, Journal of cellular physiology.

[3]  M. Rossi,et al.  Effect of Caffeine and Pentoxifylline Added Before or After Cooling on Sperm Characteristics of Stallion Sperm. , 2020, Journal of equine veterinary science.

[4]  A. Nicolaides.  The Most Severe Stage of Chronic Venous Disease: An Update on the Management of Patients with Venous Leg Ulcers , 2020, Advances in Therapy.

[5]  P. Faries,et al.  Mechanochemical ablation as an alternative to venous ulcer healing compared with thermal ablation. , 2019, Journal of vascular surgery. Venous and lymphatic disorders.

[6]  C. Lim,et al.  Diagnosis and management of venous leg ulcers , 2018, British Medical Journal.

[7]  Klára Procházková,et al.  Ginkgo biloba extract EGb 761® versus pentoxifylline in chronic tinnitus: a randomized, double-blind clinical trial , 2018, International Journal of Clinical Pharmacy.

[8]  U. Maver,et al.  Multilayered Polysaccharide Nanofilms for Controlled Delivery of Pentoxifylline and Possible Treatment of Chronic Venous Ulceration. , 2017, Biomacromolecules.

[9]  L. Varatharajan,et al.  Pharmacological adjuncts for chronic venous ulcer healing: a systematic review , 2016, Phlebology.

[10]  H. Khalili,et al.  Potential benefits of pentoxifylline on wound healing , 2016, Expert review of clinical pharmacology.

[11]  G. Sklar,et al.  Pentoxifylline-Induced Thrombocytopenia , 2015, Journal of pharmacy practice.

[12]  R. Serra,et al.  Low molecular weight heparin improves healing of chronic venous ulcers especially in the elderly , 2015, International wound journal.

[13]  E. A. Nelson,et al.  A factorial, randomized trial of pentoxifylline or placebo, four-layer or single-layer compression, and knitted viscose or hydrocolloid dressings for venous ulcers. , 2007, Journal of vascular surgery.

[14]  E. A. Nelson,et al.  Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers , 1999, BMJ.

[15]  J. Soria,et al.  Expression of Elastase and Fibrin in Venous Leg Ulcer Biopsies: A Pilot Study of Pentoxifylline Versus Placebo , 1995, Journal of cardiovascular pharmacology.

[16]  C. Barbarino,et al.  Pentoxifylline in the treatment of venous leg ulcers. , 1992, Current medical research and opinion.

[17]  P. Jones,et al.  Oxpentifylline treatment of venous ulcers of the leg. , 1990, BMJ.